Tumour-stroma interactions in carcinogenesis: Basic aspects and perspectives

Molecular and Cellular Biochemistry

Volumn 261, Issue 1, 2004, Pages 117-122

  Kiaris, H ^a   Chatzistamou, I ^a   Kalofoutis, Ch ^a   Koutselini, H ^a   Piperi, Ch ^a   Kalofoutis, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Carcinogenesis; Fibroblasts; Non autonomy effects; Stroma

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN; VASCULOTROPIN;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INTERACTION; CELL STRUCTURE; CELL TRANSFORMATION; CELL TYPE; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY LOSS; IMMUNOCYTOCHEMISTRY; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; QUANTITATIVE ANALYSIS; STROMA CELL; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; FIBROBLASTS; HUMANS; MUTATION; NEOPLASMS; STROMAL CELLS;

EID: 3442888284     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000028746.54447.6c     Document Type: Article

References (31)

1. Hahn WC, Weinberg RA: Modelling the molecular circuitry of cancer. Nat Rev Cancer 2: 331-341, 2002
2. Howlett AR, Bissell MJ: The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell Biol 2: 79-89, 1993
3. Schurch W, Seemayer TA, Lagace R: Stromal myofibroblasts in primary invasive and metastatic carcinomas. A combined immunological, light and electron microscopic study. Virchows Arch A Pathol Anat Histopathol 391: 125-139, 1981
4. Mahfouz SM, Chevallier M, Grimaud JA: Distribution of the major connective matrix components of the stromal reaction in breast carcinoma. An immunohistochemical study. Cell Mol Biol 33: 453-467, 1987
5. Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G: Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 41: 707-712, 1988
6. Ronnov-Jessen L, Petersen OW, Bissell MJ: Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction. Physiol Rev 76: 69-125, 1996
7. Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumour cells and fibroblasts in carcinoma formation. Exp Cell Res 264: 169-184, 2001
8. Sappino AP, Schurch W, Gabbiani G: Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63: 144-161, 1990
9. Tlsty TD, Hein PW: Know thy neighbor: Stromal cells can contribute oncogenic signals. Curr Opin Genet Dev. 11: 54-59, 2001
10. Hooff van den A: Stromal involvement in malignant growth. Adv Cancer Res 50: 159-196, 1988
11. Atherton AJ, Monaghan P, Warburton MJ, Robertson D, Kenny AJ, Gusterson BA: Dipeptidyl peptidase IV expression identifies a functional sub-population of breast fibroblasts. Int J Cancer 50: 15-19, 1992
12. Garin-Chesa P, Old LJ, Rettig WJ: Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A 87: 7235-7239, 1990
13. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T: Induction of hepatocyte growth factor in fibroblasts by tumour-derived factors affects invasive growth of tumour cells: In vitro analysis of tumour-stromal interactions. Cancer Res 57: 3305-3313, 1997
14. Rasmussen AA, Cullen KJ: Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Res Treat 47: 219-233, 1998
15. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704, 1990
16. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C: Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 32: 355-357, 2002
17. McLaughlin ME, Jacks T: Thinking beyond the tumour cell: Nf1 haploinsufficiency in the tumour environment. Cancer Cell 1: 408-410, 2002
18. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF: Neurofibromas in NF1: Schwann cell origin and role of tumour environment. Science 296: 920-922, 2002
19. Schor SL, Schor AM, Rushton G: Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics. J Cell Sci 90: 401-407, 1988
20. Schor SL, Haggie JA, Durning P, Howell A, Smith L, Sellwood RA, Crowther D: Occurrence of a fetal fibroblast phenotype in familial breast cancer. Int J Cancer 37: 831-836, 1986
21. Camps JL, Chang SM, Hsu TC, Freeman MR, Hong SJ, Zhau HE, von Eschenbach AC, Chung LW: Fibroblast-mediated acceleration of human epithelial tumour growth in vivo. Proc Natl Acad Sci U S A 87: 75-79, 1990
22. Gleave M, Hsieh J, Gao C, von Eschenbach A, Chung L: Acceleration of human prostate cancer growth in vivo by factor produced by prostate and bone fibroblasts. Cancer Res 51: 3753-3761, 1991
23. Atula S, Grenman R, Syrjanen S: Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro. Exp Cell Res 235: 180-187, 1997
24. Olumi A, Grossfeld G, Hayward S, Carroll P, Tlsty T, Cunha G: Carcinoma-associated fibroblasts direct tumour progression of initiated human prostate epithelium. Cancer Res 59: 5002-5011, 1999
25. Witty JP, Wright JH, Matrisian LM: Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and mis-regulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 6: 1287-1303, 1995
26. Billingham R, Orr J, Woodhouse D: Transplantation of skin components during chemical carcinogenesis with 20-methylcholanthrene. Br J Cancer 5: 417-432, 1951
27. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z: Targeted expression of stromelysin-1 in mammary gland provides evidence of a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 125: 681-693, 1994
28. Wilson C, Heppner K, Labosky P, Hogan B, Matrisian L: Intestinal tumourigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94: 1402-1407, 1997
29. Masson R, Lefebvre O, Noel A, Fahime M, Chemard M, Wendling C, Kebers F, LeMeur M, Dierich A, Foidart J, et al.: In vivo evidence that stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 140: 1535-1541, 1998
30. Rowley D: What might a stromal response mean to prostate cancer progression? Cancer Metastasis Rev 17: 411-419, 2000
31. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA: Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumourigenesis. Cancer Res 60: 2562-2566, 2000